Business Description
Amedisys Inc
NAICS : 621610
SIC : 8082
ISIN : US0234361089
Share Class Description:
AMED: Ordinary SharesCompare
Compare
Traded in other countries / regions
AMED.USAADY.GermanyAMED.Mexico IPO Date
1994-08-17Description
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.23 | |||||
| Equity-to-Asset | 0.52 | |||||
| Debt-to-Equity | 0.44 | |||||
| Debt-to-EBITDA | 3.94 | |||||
| Interest Coverage | 5.73 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.61 | |||||
| Beneish M-Score | -2.33 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.3 | |||||
| 3-Year EBITDA Growth Rate | -23.2 | |||||
| 3-Year EPS without NRI Growth Rate | -9 | |||||
| 3-Year FCF Growth Rate | -23.5 | |||||
| 3-Year Book Growth Rate | 9.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 5.89 | |||||
| Future 3-5Y Total Revenue Growth Rate | 5.51 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.43 | |||||
| 9-Day RSI | 54.63 | |||||
| 14-Day RSI | 48.99 | |||||
| 6-1 Month Momentum % | 1.25 | |||||
| 12-1 Month Momentum % | 20.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.09 | |||||
| Quick Ratio | 1.09 | |||||
| Cash Ratio | 0.22 | |||||
| Days Sales Outstanding | 50.75 | |||||
| Days Payable | 10.36 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | 1.84 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 44.39 | |||||
| Operating Margin % | 8.12 | |||||
| Net Margin % | -0.92 | |||||
| FCF Margin % | 4.03 | |||||
| ROE % | -1.95 | |||||
| ROA % | -1.02 | |||||
| ROIC % | -7.44 | |||||
| ROC (Joel Greenblatt) % | 44.04 | |||||
| ROCE % | 4.07 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 20.39 | |||||
| PE Ratio without NRI | 22.48 | |||||
| Shiller PE Ratio | 30.87 | |||||
| PS Ratio | 1.35 | |||||
| PB Ratio | 2.8 | |||||
| Price-to-Free-Cash-Flow | 33.11 | |||||
| Price-to-Operating-Cash-Flow | 28.71 | |||||
| EV-to-EBIT | 52.65 | |||||
| EV-to-Forward-EBIT | 16.22 | |||||
| EV-to-EBITDA | 27.57 | |||||
| EV-to-Forward-EBITDA | 13.68 | |||||
| EV-to-Revenue | 1.5 | |||||
| EV-to-Forward-Revenue | 1.41 | |||||
| EV-to-FCF | 37.21 | |||||
| Price-to-Projected-FCF | 1.16 | |||||
| Price-to-Median-PS-Value | 0.97 | |||||
| Earnings Yield (Greenblatt) % | 1.9 | |||||
| FCF Yield % | 3 | |||||
| Forward Rate of Return (Yacktman) % | -2.23 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers